134 related articles for article (PubMed ID: 15927792)
1. Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages.
Litherland SA; Xie TX; Grebe KM; Davoodi-Semiromi A; Elf J; Belkin NS; Moldawer LL; Clare-Salzler MJ
J Autoimmun; 2005 Jun; 24(4):297-310. PubMed ID: 15927792
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation.
Lehtonen A; Matikainen S; Miettinen M; Julkunen I
J Leukoc Biol; 2002 Mar; 71(3):511-9. PubMed ID: 11867689
[TBL] [Abstract][Full Text] [Related]
3. GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells.
Seydel F; Garrigan E; Stutevoss B; Belkin N; Makadia B; Carter J; Shi JD; Davoodi-Semiromi A; McDuffie M; Litherland SA
J Autoimmun; 2008 Dec; 31(4):377-84. PubMed ID: 18945591
[TBL] [Abstract][Full Text] [Related]
4. M-CSF and GM-CSF regulation of STAT5 activation and DNA binding in myeloid cell differentiation is disrupted in nonobese diabetic mice.
Rumore-Maton B; Elf J; Belkin N; Stutevoss B; Seydel F; Garrigan E; Litherland SA
Clin Dev Immunol; 2008; 2008():769795. PubMed ID: 19165346
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes.
Rosen RL; Winestock KD; Chen G; Liu X; Hennighausen L; Finbloom DS
Blood; 1996 Aug; 88(4):1206-14. PubMed ID: 8695838
[TBL] [Abstract][Full Text] [Related]
6. Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in Type 1 diabetic human monocytes.
Garrigan E; Belkin NS; Alexander JJ; Han Z; Seydel F; Carter J; Atkinson M; Wasserfall C; Clare-Salzler MJ; Amick MA; Litherland SA
PLoS One; 2013; 8(10):e76919. PubMed ID: 24204704
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 infection inhibits granulocyte-macrophage colony-stimulating factor-induced activation of STAT5A in human monocyte-derived macrophages.
Warby TJ; Crowe SM; Jaworowski A
J Virol; 2003 Dec; 77(23):12630-8. PubMed ID: 14610185
[TBL] [Abstract][Full Text] [Related]
8. IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages.
Hashimoto SI; Komuro I; Yamada M; Akagawa KS
J Immunol; 2001 Oct; 167(7):3619-25. PubMed ID: 11564774
[TBL] [Abstract][Full Text] [Related]
9. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.
Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A
J Immunol; 2008 May; 180(9):5898-906. PubMed ID: 18424709
[TBL] [Abstract][Full Text] [Related]
10. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression.
Feldman GM; Rosenthal LA; Liu X; Hayes MP; Wynshaw-Boris A; Leonard WJ; Hennighausen L; Finbloom DS
Blood; 1997 Sep; 90(5):1768-76. PubMed ID: 9292509
[TBL] [Abstract][Full Text] [Related]
11. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction.
Jiao H; Yang W; Berrada K; Tabrizi M; Shultz L; Yi T
Exp Hematol; 1997 Jul; 25(7):592-600. PubMed ID: 9216734
[TBL] [Abstract][Full Text] [Related]
12. IL10 resistant PGS2 expression in at-risk/Type 1 diabetic human monocytes.
Litherland SA; Xie TX; Grebe KM; Li Y; Moldawer LL; Clare-Salzler MJ
J Autoimmun; 2004 May; 22(3):227-33. PubMed ID: 15041043
[TBL] [Abstract][Full Text] [Related]
13. Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes.
Yamaoka K; Otsuka T; Niiro H; Arinobu Y; Niho Y; Hamasaki N; Izuhara K
J Immunol; 1998 Jan; 160(2):838-45. PubMed ID: 9551919
[TBL] [Abstract][Full Text] [Related]
14. Activation of a functionally distinct 80-kDa STAT5 isoform by IL-5 and GM-CSF in human eosinophils and neutrophils.
Caldenhoven E; van Dijk TB; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
Mol Cell Biol Res Commun; 1999 May; 1(2):95-101. PubMed ID: 10356357
[TBL] [Abstract][Full Text] [Related]
15. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
Natarajan C; Sriram S; Muthian G; Bright JJ
Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells.
Tanimoto A; Murata Y; Wang KY; Tsutsui M; Kohno K; Sasaguri Y
J Biol Chem; 2008 Feb; 283(8):4643-51. PubMed ID: 18089573
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.
Ooi J; Tojo A; Asano S; Sato Y; Oka Y
Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081
[TBL] [Abstract][Full Text] [Related]
18. Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction.
Litherland SA; Grebe KM; Belkin NS; Paek E; Elf J; Atkinson M; Morel L; Clare-Salzler MJ; McDuffie M
J Immunol; 2005 Oct; 175(7):4561-5. PubMed ID: 16177100
[TBL] [Abstract][Full Text] [Related]
19. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
Chakraborty A; Dyer KF; Tweardy DJ
Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis.
Nagenborg J; Jin H; Ruder AV; Temmerman L; Mees B; Schalkwijk C; Müller-Klieser D; Berg T; Goossens P; Donners MMPC; Biessen EAL
Front Immunol; 2023; 14():1165306. PubMed ID: 37920458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
